Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocugen (OCGN) EBIT: 2014-2024

Historic EBIT for Ocugen (OCGN) over the last 11 years, with Dec 2024 value amounting to -$54.8 million.

  • Ocugen's EBIT fell 33.00% to -$17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$59.8 million, marking a year-over-year decrease of 13.96%. This contributed to the annual value of -$54.8 million for FY2024, which is 16.44% up from last year.
  • Latest data reveals that Ocugen reported EBIT of -$54.8 million as of FY2024, which was up 16.44% from -$65.5 million recorded in FY2023.
  • Ocugen's EBIT's 5-year high stood at -$21.3 million during FY2020, with a 5-year trough of -$89.1 million in FY2022.
  • Moreover, its 3-year median value for EBIT was -$65.5 million (2023), whereas its average is -$69.8 million.
  • Its EBIT has fluctuated over the past 5 years, first crashed by 172.62% in 2021, then increased by 26.43% in 2023.
  • Yearly analysis of 5 years shows Ocugen's EBIT stood at -$21.3 million in 2020, then tumbled by 172.62% to -$58.0 million in 2021, then plummeted by 53.50% to -$89.1 million in 2022, then grew by 26.43% to -$65.5 million in 2023, then grew by 16.44% to -$54.8 million in 2024.